Well, if this China deal goes through, then the Bintai deal would be a master stroke with a successful vaccine and adding any additional deals as well.

Looking at potential multi billions on sales.

And yes, I still believe we need news. One it helps with Generex in short term and two it will still help in value of NGIO at listing because they will get valued based on the deals and news anyways.